News
OncClub
All Oncology News
Pipeline Report
Media
Insights
Medical World News
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
The Talk
Conferences
Conference Coverage
Conference Listing
Events
Giants of Cancer Care
PER Events
Scientific Interchanges
State of the Science Summit / IPC
Webinars
Partners
Publications
OncologyLive
Oncology Fellows
Supplements And Featured Publications
All Publications
CME/CE
Resources
Interactive Tools
Learning Modules
Presentations
Sponsored
Subscribe
Print Subscription
eNewsletter

logo
Spotlight
OncClub: Join the Chat on Trending Trials in Cancer
In-person and virtual events just for HCPs
Specialty
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
OncClub
All Oncology News
Pipeline Report
Insights
Medical World News
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
The Talk
Conference Coverage
Conference Listing
Giants of Cancer Care
PER Events
Scientific Interchanges
State of the Science Summit / IPC
Webinars
Partners
OncologyLive
Oncology Fellows
Supplements And Featured Publications
All Publications
CME/CE
Interactive Tools
Learning Modules
Presentations
Sponsored
Print Subscription
eNewsletter
Advertisement
Urothelial Cancer
| Breast Cancer
| Lung Cancer
| Gastrointestinal Cancer
| Genitourinary Cancers
| Ovarian Cancer
| Prostate Cancer
| Melanoma & Skin Cancer
| Mantle Cell Lymphoma
| Myeloproliferative Neoplasms
| Biosimilars
| Brain Cancer
| Business Management
| CAR T-cell Therapy
| COVID-19
| Chronic Lymphocytic Leukemia
| Colorectal Cancer
| Disparities in Cancer Care
| Global Oncology
| Gynecologic Oncology
| Head & Neck Cancers
| Hematologic Oncology
| Immuno-Oncology
| Multiple Myeloma
| Neoadjuvant HER2+
| Non-Hodgkin Lymphoma
| Oncology Nursing News
| Pediatric Oncology
| Precision Medicine in Oncology®
| Sarcomas/TGCT
| Supportive Care
View All >>
  • Biosimilars
  • Brain Cancer
  • Breast Cancer
  • Business Management
  • CAR T-cell Therapy
  • COVID-19
  • Chronic Lymphocytic Leukemia
  • Colorectal Cancer
  • Disparities in Cancer Care
  • Gastrointestinal Cancer
  • Genitourinary Cancers
  • Global Oncology
  • Gynecologic Oncology
  • Head & Neck Cancers
  • Hematologic Oncology
  • Immuno-Oncology
  • Lung Cancer
  • Mantle Cell Lymphoma
  • Melanoma & Skin Cancer
  • Multiple Myeloma
  • Myeloproliferative Neoplasms
  • Neoadjuvant HER2+
  • Non-Hodgkin Lymphoma
  • Oncology Nursing News
  • Ovarian Cancer
  • Pediatric Oncology
  • Precision Medicine in Oncology®
  • Prostate Cancer
  • Sarcomas/TGCT
  • Supportive Care
  • Urothelial Cancer

SPOTLIGHT -

OncClub: Join the Chat on Trending Trials in Cancer
| In-person and virtual events just for HCPs

Breast Cancer: A Continuum of Care

home / peer-exchange / breast10-care-continuum
Breast Cancer: Genomic Testing for Adjuvant Therapy

EP. 1: Breast Cancer: Genomic Testing for Adjuvant Therapy

February 22nd 2017
MINDACT Trial Design and Results in Breast Cancer

EP. 2: MINDACT Trial Design and Results in Breast Cancer

February 22nd 2017
Breast Cancer: Genomic Testing

EP. 3: Breast Cancer: Genomic Testing

February 22nd 2017
Comparison of Prognostic Tests in Breast Cancer

EP. 4: Comparison of Prognostic Tests in Breast Cancer

February 22nd 2017
Breast Cancer: Extended Adjuvant Endocrine Therapy

EP. 5: Breast Cancer: Extended Adjuvant Endocrine Therapy

February 22nd 2017
FALCON Trial Data in HR+ Metastatic Breast Cancer

EP. 6: FALCON Trial Data in HR+ Metastatic Breast Cancer

February 22nd 2017
Ribociclib for HR+ Advanced Breast Cancer

EP. 7: Ribociclib for HR+ Advanced Breast Cancer

February 22nd 2017
Emerging Role of Abemaciclib for HR+ Advanced Breast Cancer

EP. 8: Emerging Role of Abemaciclib for HR+ Advanced Breast Cancer

February 22nd 2017
Everolimus for HR+ Metastatic Breast Cancer

EP. 9: Everolimus for HR+ Metastatic Breast Cancer

February 22nd 2017
PI3K Inhibitors in HR+ Metastatic Breast Cancer

EP. 10: PI3K Inhibitors in HR+ Metastatic Breast Cancer

February 22nd 2017
HER2-Targeted Therapy in Early Stage HER2+ Breast Cancer

EP. 11: HER2-Targeted Therapy in Early Stage HER2+ Breast Cancer

February 22nd 2017
Extended Adjuvant Therapy for HER2+ Early Breast Cancer

EP. 12: Extended Adjuvant Therapy for HER2+ Early Breast Cancer

February 22nd 2017
Treating HER2+ Metastatic Breast Cancer

EP. 13: Treating HER2+ Metastatic Breast Cancer

February 22nd 2017
BRCA1/2 Status and Homologous Repair Deficiency in TNBC

EP. 14: BRCA1/2 Status and Homologous Repair Deficiency in TNBC

February 22nd 2017
Immunotherapy for TNBC

EP. 15: Immunotherapy for TNBC

February 22nd 2017
Antibody-Drug Conjugates for TNBC

EP. 16: Antibody-Drug Conjugates for TNBC

February 22nd 2017

Latest Conference Coverage

Further Understanding of Immune Mechanisms in Tumor Microenvironment Is Key to Advancing Immunotherapy in Solid Tumors

Navigating Systemic Therapy for RCC: Balancing Risk Status and Response

ADCs, Novel Targets Represent Next Wave of Treatment Advances in mCRPC

Precision Medicine in Prostate Cancer Care: Keeping Up With Evolving Guidance for Testing and Decision Making

View More Latest Conference Coverage
Advertise
About OncLive
Editorial Board
CancerNetwork.com
CGTlive.com
CureToday.com
OncNursingNews.com
TargetedOnc.com
Contact Us
Privacy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Clarke Drive
Cranbury, NJ 08512

609-716-7777

© 2023 MJH Life Sciences

All rights reserved.
Home
About Us
News
Contact